Skip to content

Effects of capsular distension with combined hyaluronic acid and corticosteroids in the treatment of primary frozen shoulder: a randomized, double-blind comparison with capsular distension with corticosteroids alone

Effects of capsular distension with combined hyaluronic acid and corticosteroids in the treatment of primary frozen shoulder: a randomized, double-blind comparison with capsular distension with corticosteroids alone

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062342
Enrollment
Unknown
Registered
2022-08-02
Start date
2022-08-04
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frozen shoulder

Interventions

1:capsular distension with combined hyaluronic acid and corticosteroids
2:capsular distension with corticosteroids alone

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.at least 1 month of shoulder pain duration; 2.restriction of passive motion of greater than 30° in 2 or more planes ofmovement; 3.age>=18 years; 4.availability of radiographs and MRI of the affected shoulder to exclude secondary causes of frozen shoulder.

Exclusion criteria

Exclusion criteria: 1. bilateral frozen shoulder; 2.secondary shoulder stiffness including inflammatory or infectious arthritis, previous fracture, rotator cuff lesion, glenohumeral instability; 3. shoulder surgery histroy; 4.NSAID treatment within 2 weeks,oral corticosteroids within 4 weeks,or regular use of analgesics or anti-inflammatory drugs taken for conditions not related to shoulder pain; 5..Intra-articular injections of viscosupplementation (e.g. hyaluronic acid) or corticosteroirds within 6 months; 6.Dermatological diseases at shoulder region contraindicating intra-articular injection; 7.Women who are pregnant or plan to get pregnant or breast-feeding in the project period.

Design outcomes

Primary

MeasureTime frame
12-week SPADI;

Secondary

MeasureTime frame
SPADI at other time points;VAS score;Constant-Murley score;GROC Rating of Change at all Follow-up Assessments score;Shoulder range of motion;MRI measurements;Concomitant Pain medication Use and Surgery;

Countries

China

Contacts

Public ContactJinzhong Zhao
jzzhao@sjtu.edu.cn+86 18930177160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026